14 unknown, 11 completed, 1 not yet recruiting, 1 recruiting. 18 Phase 4, 5 Not applicable, 1 Early Phase 1, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 18 | Unknown 10, Completed 7, Recruiting 1 |
| Not applicable | 5 | Unknown 4, Completed 1 |
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Furazolidone: new trials by email Literature Review of Furazolidone trials Research Report on Furazolidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment Bismuth, Esomeprazole, Tetracycline - Gastritis, Dyspepsia | Phase 4 | Recruiting | Yongquan Shi | 1248 | 2025-10-28 | 2025-12-02 |
| The Efficacy and Safety of Keverprazan for Helicobacter Pylori Eradication Keverprazan, Amoxicillin, Furazolidone - Helicobacter Pylori Infection | Early Phase 1 | Not yet recruiting | Nanjing First Hospital, Nanjing Medical University | 672 | 2025-03-01 | 2025-01-16 |
| Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy Vonoprazan, amoxicillin, Bismuth - Gastritis Dyspepsia Helicobacter Pylori Infection Gastric Cancer Peptic Ulcer | Phase 4 | Completed | Yongquan Shi | 688 | 2023-06-06 | 2025-07-03 |
| Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection Rabeprazole, Colloidal Bismuth Pectin Granules, Amoxicillin - Helicobacter Pylori Infection | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 855 | 2023-03-01 | 2023-05-15 |
| Furazolidone Quadruple Regimen Eradicate H. Pylori Infection Furazolidone, Clarithromycin - Helicobacter Pylori Infection, Eradication | Phase 1 / Phase 2 | Completed | Liaocheng People's Hospital | 493 | 2022-08-01 | 2025-02-12 |
| The Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure Amoxicillin,Furazolidone, Amoxicillin,Levofloxacin, Tetracycline,Furazolidone - Helicobacter Pylori Infection | Completed | Shandong University | 670 | 2021-12-30 | 2023-02-17 | |
| Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin Furazolidone, Metronidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 170 | 2021-11-28 | 2021-11-30 |
| Efficacy and Safety of 14-day Concomitant Therapy for Difficult-to-Treat Helicobacter Pylori Infection three kinds of antibiotics including amoxicillin，tetracycline, furazolidone, levofloxacin,clarithromycin,levofloxacin,tinidazole,metronidazol - Helicobacter Pylori Infection | Not applicable | Unknown | Xiuli Zuo | 60 | 2021-11-20 | 2021-12-01 |
| Differences in the Eradication of Helicobacter Pylori by Different Therapies Group1 Vonoprazan Fumarate + amoxicillin + doxycycline, Group2 Vonoprazan Fumarate + furazolidone + doxycycline, Group3 esomeprazole + colloidal bismuth tartrate + amoxicillin + doxycycline - Helicobacter Pylori Infection | Not applicable | Unknown | wang xiaoyan | 100 | 2021-06-17 | 2022-02-18 |
| Efficacy and Safety of Vonoprazan as First-line Treatment for Helicobacter Pylori Eradication Vonoprazan, Esomeprazole, Colloidal bismuth pectin - Helicobacter Pylori Infection | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 234 | 2021-05-18 | 2021-06-01 |
| Efficacy and Safety Study of Egg Yolk Antibody in Adjuvant Treatment of Helicobacter Pylori Infection Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline, Bismuth, IIaprazole, Amoxicillin/Clarithromycin/Furazolidone, Doxycycline, Bismuth, Yolk antibody and IIaprazole, Amoxicillin/ Clarithromycin/Furazolidone, Doxycycline - Helicobacter Pylori Infection | Not applicable | Unknown | The Third Xiangya Hospital of Central South University | 100 | 2021-04-06 | 2022-12-09 |
| Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection esomeprazole plus amoxicillin, amoxicillin, furazolidone, bismuth potassium citrate , esomeprazole - H. Pylori Infection | Not applicable | Unknown | Shanghai Zhongshan Hospital | 186 | 2021-01-01 | 2022-08-05 |
| Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy Esomeprazole, Amoxicillin, Bismuth - Gastritis, Dyspepsia | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 658 | 2020-12-20 | 2023-01-31 |
| The Study on the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure Amoxicillin , Levofloxacin and Esomeprazole, Amoxicillin , Furazolidone and Esomeprazole, Tetracycline , Furazolidone and Esomeprazole - Helicobacter Pylori | Completed | Shandong University | 820 | 2020-07-01 | 2022-10-27 | |
| Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin Furazolidone, Tinidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 250 | 2019-11-01 | 2021-11-18 |
| Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 60 | 2019-04-01 | 2019-03-08 |
| Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection two sensitive antibiotics(amoxicillin, clarithromycin, metronidazole, tinidazole, levofloxacin, furazolidone and tetracycline), one proton pump inhibitor, colloidal bismuth pectin, two antibiotics based on personal medication history(amoxicillin,levofloxacin, furazolidone) - Helicobacter Pylori Infection | Phase 4 | Completed | Shandong University | 420 | 2019-01-01 | 2020-05-12 |
| A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection esomeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days), rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 120 | 2018-12-15 | 2018-12-04 |
| Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy Berberine, Amoxicillin, Esomeprazole - Gastric Ulcer, Chronic Gastritis | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 658 | 2018-08-01 | 2019-08-30 |
| A Comparison of Clarithromycin-based and Furazolidone-based Bismuth-containing Regimens for H. Pylori Eradication Furazolidone, Clarithromycin - Helicobacter Pylori | Phase 4 | Completed | Shandong University | 350 | 2018-07-31 | 2020-06-23 |
Showing 20 of 27. Sign in to see all of them.
Gastritis (3) · Stomach Neoplasms (3) · Dyspepsia (2) · Peptic Ulcer (2) · Duodenal Ulcer (1) · Stomach Ulcer (1)
Shandong University (10) · Second Affiliated Hospital, Zhejiang University, School of Medicine (2) · The Third Xiangya Hospital of Central South University (2) · Xijing Hospital of Digestive Diseases (2) · Yongquan Shi (2) · Aga Khan University (1) · Liaocheng People's Hospital (1) · Nanjing First Hospital, Nanjing Medical University (1) · Shanghai Jiao Tong University School of Medicine (1) · Shanghai Zhongshan Hospital (1) · Sir Run Run Shaw Hospital (1) · Xiuli Zuo (1) · Yanqing Li (1) · wang xiaoyan (1)
China (24) · Pakistan (1)
Xiuli Zuo, MD,PhD (7) · Li Yanqing, MD, PhD (2) · Xiuli Zuo, PhD,MD (2) · Lifeng Liu (1) · Qin Du, Master (1) · Wei Jiang, MD (1) · Weiling Hu, Attending (1) · Xiuli Zuo (1) · Zaigham Abbas, FACG (1)
PMID 19058002, PMID 23376004, PMID 25801708, PMID 32348007, PMID 34397042, PMID 36193978, PMID 36458325, PMID 37214450, PMID 37479526, PMID 39495800, PMID 39924352, PMID 40304303, PMID 40543051